The study analyzes the interaction between the trading behaviour of 1024 moving average and momentum models and the fluctuations of the yen/dollar exchange rate. I show first that these models would have exploited exchange rate trends quite profitably between 1976 and 2007. I then show that the aggregate transactions and positions of technical models exert an excess demand pressure on currency markets since they are mostly on the same side of the market. When technical models produce trading signals almost all of them are either buying or selling, when they maintain open positions they are either long or short. A strong interaction prevails between exchange rate movements and the transactions triggered by technical models. An initial rise of the exchange rate due to news, e.g., is systematically lengthened through a sequence of technical buy signals. 相似文献
Background: Evidence of the cost-efficacy of ixekizumab for the treatment of moderate-to-severe plaque psoriasis (PsO) in the US is limited.Objective: To estimate the number needed to treat (NNT) and monthly cost of achieving one additional Psoriasis Area and Severity Index (PASI) 75, 90, and 100 responder for ixekizumab and other Food and Drug Administration (FDA)-approved biologics in PsO.Methods: A network meta-analysis estimated the probability of achieving PASI 75, 90, or 100 response during induction for each biologic. NNTs were calculated using response difference of each respective biologic vs placebo at the end of induction. Monthly costs per additional PASI responder were based on FDA-approved doses, wholesale acquisition costs, and induction NNTs.Results: Induction NNTs for ixekizumab 80?mg once every 2 weeks (Q2W) relative to placebo were consistently lower across all levels of clearance compared with the other biologics. Monthly cost per additional responder was lowest for ustekinumab 45?mg at PASI 75 and for secukinumab 300?mg and ixekizumab 80?mg Q2W at PASI 90. Ixekizumab 80?mg Q2W had the lowest cost for PASI 100.Conclusion: In this analysis, ixekizumab is the most cost-efficient biologic in the US when targeting complete resolution, as measured by PASI 100 in PsO. 相似文献
Background: Chronic lymphocytic leukemia (CLL) is an orphan disease that primarily affects the elderly. The majority of symptomatic patients eligible for frontline treatment are unfit for fludarabine based chemoimmunotherapy. Historical treatment includes chlorambucil (Chl), bendamustine/rituximab (BR), and chlorambucil/rituximab/ChlR combination. Clinical guidelines now recommend the use of novel agents, such as ibrutinib (Ibr), in both frontline and relapse settings and other novel agents, such as idelalisib (with rituximab), in relapse settings. Despite compelling clinical results for novel agents, follow-up in clinical trials is relatively short and, thus, the comparative long-term benefits are still unknown.
Materials and methods: The authors developed a simulation model to generate treatment specific lifetime estimates of Overall Survival (OS) and Quality Adjusted Life Years (QALYs) for treatment with BR, Chl, ChlR, and Ibr. Two potential clinical scenarios were modelled: with and without novel agents for treating CLL. The model was based on health states relating to first- and second-line progression-free survival (PFS), post-progression survival, and death.
Results: Where novel agents were assumed unavailable, mean OS ranged from 5.4–8.5 years and QALYs from 3.5–6.1. Where novel agents were available, the mean OS increased to 10.0 years, with a corresponding increase in QALYs to 7.6. Frontline Ibr use followed by Physician’s Choice, including novel agents at relapse, resulted in projected increase in OS of between 18% (1.5 years) and 85% (4.6 years), corresponding to a 25–117% increase in QALYs, compared with currently available traditional therapies.
Limitations: The limitations of this analysis include immature OS data and the assumption of equivalent efficacy across all novel agents in terms of their impact on PFS and OS.
Conclusions: The use of novel agents is predicted to yield substantive gains in predicted lifetime OS and QALY improvements compared to traditional therapies in CLL patients who are ineligible for fludarabine-based chemoimmunotherapy. 相似文献
This study tested a conceptual model in order to examine the role of specific image formation agents in forming destination image and place attachment from the perspective of pop star fans. By examining each construct’s subdimensions, the significant path analysis results supported the proposed model and offered a holistic view of the relationships among the variables, thus extending the literature. Findings suggested that autonomous image formation agents have d3istinct roles in forming destination image and place attachment in comparison with induced and organic agents. The findings highlight the important role of destination image in mediating the relationship between image formation agents and place attachment. This study further revealed a direct impact of image formation agents on place attachment dimensions. Meaningful implications for destination marketers are presented. 相似文献
This paper presents a two-stage development model for low-carbon tourism (LCT). In study I, a qualitative questionnaire was developed using the Delphi and analytic hierarchy process methods, and this was then distributed to 19 experts, whose opinions were used to develop a complete index system for low-carbon tours. In study II, 393 tourists questionnaires administered in the Sun Moon Lake National Scenic Area were utilized to determine whether the index system would affect visitor purchase intentions. The findings showed that the LCT index system positively influenced tourists' purchase intentions, and their actual purchase behaviors toward low-carbon products. However, this study empirically found that there are significant differences with regard to what these two groups (experts and tourists) view as important in a low-carbon tour system. The contributions of this study include: (1) confirming the importance of the multiple perspectives obtained from the travel industry and tourists to establish the LCT system; (2) using the case study to investigate tourists' opinions to better understand whether the LCT index that was developed based on the industry perspective in stage one was appropriate; and (3) offering practical suggestions to help businesses better understand specific trends and plans for LCT. 相似文献
The influence of neutral agents on the evolutionary dynamics of social tolerance is discussed based on a recently proposed economic interaction model with local social cost functions. We show that the dynamical structure of social tolerance is completely changed even if a few neutral agents are introduced into the society. Especially, the full intolerance steady state, which is stable in previous works, becomes unstable and avoidable due to the economic incentive introduced by the neutral agents. The necessary condition of achieving full tolerance is also reduced compared to previous works without neutral agents. 相似文献